29 Nov 2023 Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure Member news
28 Nov 2023 argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia Member news
15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
19 Oct 2023 Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission Member news
18 Oct 2023 Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome Member news
09 Oct 2023 SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform Member news
06 Oct 2023 Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial Member news
04 Oct 2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
